Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.97B P/E - EPS this Y 1.70% Ern Qtrly Grth -
Income -802.69M Forward P/E -5.21 EPS next Y 19.20% 50D Avg Chg 8.00%
Sales 328.6M PEG - EPS past 5Y - 200D Avg Chg 13.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -25.00%
Recommedations 1.70 Quick Ratio 2.46 Shares Outstanding 171.85M 52W Low Chg 36.00%
Insider Own 0.95% ROA -24.77% Shares Float 160.60M Beta 1.11
Inst Own 111.31% ROE - Shares Shorted/Prior 12.22M/13.50M Price 21.77
Gross Margin 77.61% Profit Margin -244.27% Avg. Volume 979,658 Target Price 88.53
Oper. Margin -205.01% Earnings Date Oct 24 Volume 1,034,090 Change -1.63%
About Insmed Incorporated

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.

INSM Chatroom

User Image PeteyUSA Posted - 3 hours ago

I’m all or nothing. I’m not selling a share. It’s worth the risk. I’ll be so mad at myself if this skyrockets. I went through this with $INSM I bought a significant amount at about $17, I held it for two years and it never did anything. It dropped 8% on a Friday and I seriously considered selling. By that very next Monday (thought all weekend about getting out) it was on it’s way to making me a 300% gain.

User Image Torrrrrr Posted - 12 hours ago

$INSM What I just wonder is, Who's the buyer? MRK? PFE? Lily?

User Image pianoman439 Posted - 1 day ago

$INSM I’m not seeing a buyout for less than 150.

User Image Riley_Cummings Posted - 1 day ago

$INSM $SRPT LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

User Image TheDayTradingAcademy Posted - 1 day ago

Shares of the global biopharmaceutical company $INSM rallied +10.67% on Tuesday at $73.72, after the U.S. drugmaker terminated a $500M equity sales agreement with health-care investment bank Leerink Partners.The stock is down -4.27% in the past 3 months, but up +137.88% in 2024 & +210.66% y/y, with a market cap of $11.92B.

User Image LEVRUP Posted - 1 day ago

$INSM 👀 👀

User Image ms1sd Posted - 2 days ago

@Kingjake26 please check into it, when you get a chance..I respect your input. One more, go to $INSM and see the post that shows Darwin Global Mgt's bold position and let me know your thoughts...thx!

User Image Dy2ski Posted - 2 days ago

$INSM Hmmmm... Interesting that this recently entered agreement was terminated. Certainly, doesn't sound like they utilized the full allotment. https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=318730765&type=HTML&symbol=INSM&cdn=14471f7725e7ae1244bf8f211234a472&companyName=Insmed+Incorporated&formType=8-K&dateFiled=2024-11-19

User Image SkSk_ Posted - 6 days ago

$INSM holy hell. darwin global management is damn near all in on INSM. bio hedge funds VERY rarely make one stock ~60% of their port... they now $766 million of shares. I do really think this company gets bought out by JPM. its an expensive acquisition to be sure, but there are really not too many commercial-ready, blockbuster drugs out there. I will be looking at January 2025 calls to capitalize on massive upside from a buyout.

User Image look2theblue Posted - 1 week ago

$ITRM I believe there is some literature for it's use in Non Tuberculosis Mycobacterium, which would be a nice complement to or interest for $INSM which markets Arikayce inhaled.

User Image LauriceGeel Posted - 1 week ago

📈 Stock Performance for $INSM over the Last Month: Opening Price: $74.56 Closing Price: $70.14 Highest Price: $77.70 Lowest Price: $65.95 Percentage Change: -5.93% 📊 Financial Summary: Revenue: 305,208,000 Net Income: -749,567,000 Total Assets: 1,329,837,000 Total Liabilities: 1,661,760,000 Operating Cash Flow: N/A Note: For a secret strategy and more detailed information, please visit the link in my bio. Thank you!

User Image Igotzthis Posted - 1 week ago

$INSM What about Clofazimine? Could be a game changer in ntm.

User Image TickerDD_com Posted - 1 week ago

$INSM How much is INSM Shorted? What is Short Interest for INSM? https://youtu.be/9--Wtp19dTI

User Image look2theblue Posted - 1 week ago

$ITRM Also good for NTM (non tuberculosis mycobacterium) which is a lucrative market see $INSM marketcap.

User Image InItToWinIt100 Posted - 2 weeks ago

$INSM $SNOW

User Image TickerDD_com Posted - 2 weeks ago

$INSM 5 Strategies that Benefit INSM and its company Insmed https://youtu.be/q7g5iKXn2GE

User Image pianoman439 Posted - 2 weeks ago

$INSM industry panicking over RFK Jr. Do things right, and you will have nothing at all to fear!

User Image JuggernautRaider Posted - 2 weeks ago

$TNXP is Headquartered near $ADCT and $INSM and $ABBV in New Jersey. Also not far from $GILD’s New Jersey office. $TNXP is a hidden gem. Tonix Pharmaceuticals is intriguing pre reverse split

User Image triskis Posted - 10/31/24

$INSM $NVDA $SMCI $LTBR $OKLO

User Image vinnymaggi Posted - 10/31/24

$INSM 1.5 Billion COH increased spending because of an ADDITIONAL 120 reps in the field Rev up 18%+ Heavy call buying , this is temp $66

User Image OpenOutcrier Posted - 10/31/24

$INSM (-7.2% pre) Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update https://finance.yahoo.com/news/insmed-reports-third-quarter-2024-110000536.html

User Image Dy2ski Posted - 10/29/24

$INSM https://finance.yahoo.com/video/play-biotech-stocks-insmed-wave-214722301.html

User Image iHitPredict Posted - 10/29/24

$INSM whoever is playing $71 and $75 game here is a winner. Coz I am one of them. Pick before $75, exit wait for reentry at $71.. 4 points winner everytime since 6 months, showing the same trend. $OKLO my baby, $SMCI my step son, $LTBR my step baby, and $NVDA my daddy. You just can’t go wrong!! Play it safe—this is not financial advice, and I’m not encouraging anyone to gamble.

User Image pianoman439 Posted - 10/29/24

$INSM looks like they tried some sneaky after hours trades that failed to crash the share price.

User Image Estimize Posted - 10/28/24

Estimize revenue expectations are 0.18% higher than that of Wall Street for $INSM Q3 [Reporting 10/31 BMO] http://www.estimize.com/intro/in

User Image MerrillBarney Posted - 10/25/24

$TVGN Hey, $INSM I was wrong about you. But can you tell Uncle $GS Goldman to come ovrer here and do the same magic. I know success will be inevitable with his help.

User Image swingingtech Posted - 1 month ago

$INSM $ORA $BPMC https://wallstreetwaves.com/significant-friday-options-trading-insm-ora-bpmc-insights/

User Image swingingtech Posted - 1 month ago

$IWM $FTAI $PCVX $INSM https://wallstreetwaves.com/significant-capital-inflows-observed-in-etfs-focus-on-iwm-ftai-pcvx-and-insm/

User Image MerrillBarney Posted - 1 month ago

$TVGN $INSM I'll admit I was wrong about you. But here's your sister with a similar pedigree. I mean, we don't have Uncle Goldman to do his out of this world magic. But it is still worth looking into. Just sayin

User Image MujRaf Posted - 1 month ago

$INSM $TVGN

Analyst Ratings
Cantor Fitzgerald Overweight Sep 9, 24
HC Wainwright & Co. Buy Aug 29, 24
Truist Securities Buy Aug 12, 24
HC Wainwright & Co. Buy Aug 12, 24
TD Cowen Buy Aug 9, 24
UBS Buy Aug 9, 24
Stifel Buy Aug 9, 24
Morgan Stanley Overweight Jul 12, 24
Goldman Sachs Buy Jul 10, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wise John Drayton Chief Commercial Off.. Chief Commercial Officer Jan 03 Sell 29.26 21,238 621,424 115,690 01/05/24
Wise John Drayton Chief Commercial Off.. Chief Commercial Officer Jan 03 Option 19.11 20,071 383,557 124,055 01/05/24
Smith Michael Alexander General Counsel, Sen.. General Counsel, Senior VP Jan 04 Sell 29.31 627 18,377 88,737 01/05/24
Schaeffer Orlov S Nicole Chief People Strateg.. Chief People Strategy Officer Jan 04 Sell 29.28 1,457 42,661 105,149 01/05/24
Lewis William Chair and CEO Chair and CEO Jan 04 Sell 29.26 6,979 204,206 373,538 01/05/24
Flammer Martina M.D. Chief Medical Office.. Chief Medical Officer Jan 04 Sell 29.21 1,386 40,485 117,525 01/05/24
Adsett Roger Chief Operating Offi.. Chief Operating Officer Jan 04 Sell 29.21 3,042 88,857 161,183 01/05/24
Adsett Roger Chief Operating Offi.. Chief Operating Officer Jun 13 Sell 19.32 8,981 173,513 151,352 06/15/23
Wise John Drayton Chief Commercial Off.. Chief Commercial Officer Jan 10 Sell 17.96 779 13,991 77,272 01/12/23
Smith Michael Alexander General Counsel, Sen.. General Counsel, Senior VP Jan 10 Sell 17.93 1,836 32,919 54,332 01/12/23
Schaeffer Orlov S Nicole Chief People Strateg.. Chief People Strategy Officer Jan 10 Sell 17.95 2,435 43,708 72,159 01/12/23
Lewis William Chair and CEO Chair and CEO Jan 10 Sell 18 6,994 125,892 265,067 01/12/23
Flammer Martina M.D. Chief Medical Office.. Chief Medical Officer Jan 10 Sell 18.06 3,439 62,108 72,763 01/12/23
Bonstein Sara Chief Financial Offi.. Chief Financial Officer Jan 10 Sell 18.12 2,857 51,769 66,031 01/12/23
Adsett Roger Chief Operating Offi.. Chief Operating Officer Jan 10 Sell 17.99 3,194 57,460 135,487 01/12/23
Wise John Drayton Chief Commercial Off.. Chief Commercial Officer Nov 22 Sell 18.84 7,154 134,781 71,613 11/22/22
Adsett Roger Chief Operating Offi.. Chief Operating Officer Nov 22 Sell 18.80 11,855 222,874 134,127 11/22/22
SHAROKY MELVIN MD Director Director Oct 31 Buy 17.62 30,000 528,600 15,900 11/02/22
LEE LEO Director Director Oct 31 Buy 17.69 45,000 796,050 98,265 11/02/22
Smith Michael Alexander General Counsel, Sen.. General Counsel, Senior VP Jul 12 Sell 23.40 941 22,019 50,455 07/12/22
Lewis William Chair and CEO Chair and CEO Jul 07 Option 16.16 96,614 1,561,282 353,330 07/08/22
Lewis William Chair and CEO Chair and CEO Jul 07 Sell 23 96,614 2,222,122 256,716 07/08/22
SHAROKY MELVIN MD Director Director May 11 Buy 17.2 20,000 344,000 262,621 05/13/22
Lewis William Chair and CEO Chair and CEO Mar 23 Option 15.52 96,614 1,499,449 218,605 03/25/22
Lewis William Chair and CEO Chair and CEO Mar 23 Sell 23.31 96,614 2,252,072 217,624 03/25/22
Lewis William Chair&Chief Executiv.. Chair&Chief Executive Officer Nov 06 Option 6.24 235,000 1,466,400 164,787 11/06/20
Lewis William Chair&Chief Executiv.. Chair&Chief Executive Officer Nov 06 Sell 34.08 200,000 6,816,000 129,787 11/06/20
Pellizzari Christine A Chief Legal Officer Chief Legal Officer Nov 05 Option 12.19 183,450 2,236,256 134,002 11/05/20
Pellizzari Christine A Chief Legal Officer Chief Legal Officer Nov 05 Sell 33.01 143,796 4,746,706 94,348 11/05/20
SHAROKY MELVIN MD Director Director Sep 16 Sell 30.69 20,000 613,800 236,890 09/16/20